# Melanotan I in acute stroke: phase 2a safety trial

Source: https://pepvault.app/research/melanotan-i-stanislaus-2023

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Melanotan I](https://pepvault.app/research#melanotan-i)

Clinical trial · people

# Melanotan I: well tolerated in 6 acute stroke patients

Checked against the paper November 2026 Clinical trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

This is a first small safety check of Melanotan I (afamelanotide) in stroke patients, not evidence that it improves stroke recovery.

- **Kind:** Clinical trial
- **Studied in:** People
- **Number studied:** 6
- **Published:** 2023
- **Journal:** BMC Neurol

## What they tested

The team tested whether afamelanotide (Melanotan I) could be given safely and practically to people within a day of an ischemic stroke, a stroke caused by a blocked blood vessel.

## How the study was done

An open-label phase 2a trial in 6 people with acute ischemic stroke, with no comparison group and everyone knowing they got the drug. Patients were within 24 h of onset and could not get treatments to reopen the blocked vessel. They received 16 mg implants under the skin on days 0 and 1, repeated on days 7 and 8 for those not well recovered, and were followed with checks and brain scans up to day 42.

<!--promo-->

PepVault for iPhone

## Taking Melanotan I? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

Of the 6 patients, 5 were women and the median age was 81. Two received 4 doses and four received 2. One patient died of a second stroke on day 9, tied to a known complete blockage of the internal carotid artery and judged unrelated to the drug, and no other local or major whole-body side effects were seen. In the survivors, the median NIHSS score, a stroke severity scale, went from 6 to 2 by day 7. The median area of poor blood flow on the first-day scan was 23 mL, and the area seen on later MRI scans measured 10 mL on day 3 and 4 mL on day 9.

## What it doesn’t show

With only 6 patients and no control group, the trial cannot show whether the improvement came from the drug or from natural recovery after stroke. The authors say randomized studies are needed to test the benefit.

## The paper

Stanislaus et al. A feasibility and safety study of afamelanotide in acute stroke patients - an open label, proof of concept, phase iia clinical trial. BMC Neurol. 2023.

- [PubMed (PMID 37496004)](https://pubmed.ncbi.nlm.nih.gov/37496004/)
- [The paper (DOI 10.1186/s12883-023-03338-9)](https://doi.org/10.1186/s12883-023-03338-9)
- [ClinicalTrials.gov (NCT04962503)](https://clinicaltrials.gov/study/NCT04962503)

## The compound

- [Melanotan I: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/melanotan-i)
- [Melanotan I dose guide](https://pepvault.app/lab/dosage/melanotan-i)

## With this study

### Melanotan I

- [Melanotan I: the full reference](https://pepvault.app/peptides/melanotan-i)
- [Melanotan I dose guide](https://pepvault.app/lab/dosage/melanotan-i)

### Mixing charts

- [5 mg vial](https://pepvault.app/tools/reconstitution-calculator/melanotan-i-5mg)

### Studies

- [Melanotan I: more pain-free sun time in protoporphyria trials](https://pepvault.app/research/melanotan-i-langendonk-2015)
- [Melanotan I plus UV-B: 48.64% vitiligo repigmentation at day 168](https://pepvault.app/research/melanotan-i-lim-2015)
- [All 6 studies](https://pepvault.app/research#melanotan-i)

### Compared with

- [Melanotan I vs Melanotan II](https://pepvault.app/peptides/compare/melanotan-i-vs-melanotan-ii)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

## More studies on Melanotan I

- [Melanotan I: more pain-free sun time in protoporphyria trials](https://pepvault.app/research/melanotan-i-langendonk-2015) Randomized trial · people · 2015
- [Melanotan I plus UV-B: 48.64% vitiligo repigmentation at day 168](https://pepvault.app/research/melanotan-i-lim-2015) Randomized trial · people · 2015
- [Melanotan II: erections in 17 of 20 men with erectile dysfunction](https://pepvault.app/research/melanotan-ii-wessells-2000) Clinical trial · people · 2000
- [Melanotan II: darker skin in 2 of 3 men in a small phase I trial](https://pepvault.app/research/melanotan-ii-dorr-1996) Clinical trial · people · 1996
- [Melanotan II: melanoma diagnosed in a 20-year-old woman after use](https://pepvault.app/research/melanotan-ii-hjuler-2014) Observational study · people · 2014
- [Every study on Melanotan I](https://pepvault.app/research#melanotan-i)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking Melanotan I? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking Melanotan I? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Melanotan I

- [Melanotan I: the full reference](https://pepvault.app/peptides/melanotan-i)
- [Melanotan I dose guide](https://pepvault.app/lab/dosage/melanotan-i)

### Mixing charts

- [5 mg vial](https://pepvault.app/tools/reconstitution-calculator/melanotan-i-5mg)

### Studies

- [Melanotan I: more pain-free sun time in protoporphyria trials](https://pepvault.app/research/melanotan-i-langendonk-2015)
- [Melanotan I plus UV-B: 48.64% vitiligo repigmentation at day 168](https://pepvault.app/research/melanotan-i-lim-2015)
- [All 6 studies](https://pepvault.app/research#melanotan-i)

### Compared with

- [Melanotan I vs Melanotan II](https://pepvault.app/peptides/compare/melanotan-i-vs-melanotan-ii)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

<!--promo-->

PepVault for iPhone

## Taking Melanotan I? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Melanotan I](https://pepvault.app/research#melanotan-i)

## The library

- [Melanotan I](https://pepvault.app/peptides/melanotan-i)
- [Melanotan I dose guide](https://pepvault.app/lab/dosage/melanotan-i)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
